10-day vs 5-day decitabine: equivalence cannot be concluded – Authors' reply

Nicholas J. Short; Farhad Ravandi

doi:10.1016/S2352-3026(19)30052-3

10-day vs 5-day decitabine: equivalence cannot be concluded – Authors' reply

Nicholas J. Short, Farhad Ravandi

Leukemia

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	e178
Journal	The Lancet Haematology
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/S2352-3026(19)30052-3
State	Published - Apr 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/S2352-3026(19)30052-3

Cite this

@article{58edd921b0294bbc980d9ad727b78f8f,

title = "10-day vs 5-day decitabine: equivalence cannot be concluded – Authors' reply",

author = "Short, {Nicholas J.} and Farhad Ravandi",

year = "2019",

month = apr,

doi = "10.1016/S2352-3026(19)30052-3",

language = "English (US)",

volume = "6",

pages = "e178",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - 10-day vs 5-day decitabine

T2 - equivalence cannot be concluded – Authors' reply

AU - Short, Nicholas J.

AU - Ravandi, Farhad

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85063288617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063288617&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(19)30052-3

DO - 10.1016/S2352-3026(19)30052-3

M3 - Letter

C2 - 30926077

AN - SCOPUS:85063288617

SN - 2352-3026

VL - 6

SP - e178

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 4

ER -

10-day vs 5-day decitabine: equivalence cannot be concluded – Authors' reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this